Adjuvans SRL
Adjuvans reported total assets of €1.62m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of Adjuvans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Adjuvans's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Adjuvans's financial analysis
- Solvency84.6%sector median: 57.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Adjuvans
Adjuvans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0869.753.072
- VAT number
- BE0869753072
- Peppol
- Registered · 0208:0869753072 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Oct 2004
- Registered office
- 2800 Mechelen
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Engineering activities and technical consultancy, except activities of land surveyors (NACE 71121)
Adjuvans (SRL) has been based in Mechelen since 2004, active in: engineering activities and technical consultancy, except activities of land surveyors. For 2025, it reports a net profit of 100,656 € and equity of €1.37m; its revenue is not published. Its solvency stands at 84.6%, above the median of its sector (57.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Adjuvans
Companies in the same business, of comparable size and area, outside its group.
- Brouhon Engineering activities and related technical consultancy Zaventem · balance sheet 365,937 €
- Voith Turbo Engineering activities and related technical consultancy Leuven · balance sheet €1.57m
- Van Looy Group Engineering activities and related technical consultancy Brussels · balance sheet €1.83m
- Dott. Ing. A. Modiano and C. Engineering activities and related technical consultancy Ixelles · balance sheet €1.35m
- Cocoon Build Engineering activities and related technical consultancy Olen · balance sheet €1.30m
- Koala Engineering activities and related technical consultancy Woluwe-Saint-Lambert · balance sheet €1.12m
- Avonts - Smet Techniek en Industrie Engineering activities and related technical consultancy Bornem · balance sheet 666,543 €
- JTR Engineering Engineering activities and related technical consultancy Kraainem · balance sheet €2.45m
Frequently asked questions about Adjuvans
What is the revenue of Adjuvans?
Adjuvans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Adjuvans?
In Belgium, the VAT number is the company number prefixed with BE: BE0869753072 for Adjuvans, if the company is VAT-registered. Its company number (CBE) is 0869.753.072.
Where is the registered office of Adjuvans?
According to the CBE register, the registered office of Adjuvans is in 2800 Mechelen.
What is the equity of Adjuvans?
At the close of the 2025 financial year, the equity of Adjuvans amounts to 1,369,873 €, a solvency of 84.6% of total assets.
Who manages Adjuvans?
The register lists 1 active mandates at Adjuvans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Adjuvans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →